Drugs in Context
LightNews LightNews
drugsincontext.bsky.social
Drugs in Context
@drugsincontext.bsky.social
31 followers 120 following 34 posts
Drugs in Context publishes high-quality, peer-reviewed articles covering the latest evidence and innovations in drug treatment across all therapeutic areas. JCR 2025 JIF 2.8 WoS ESCI, PubMed, Scopus, DOAJ https://www.drugsincontext.com/
www.drugsincontext.com
Posts Media Videos Starter Packs
Pinned
drugsincontext.bsky.social
Drugs in Context @drugsincontext.bsky.social · Jun 19
🎉 Exciting News! 🎉

We are thrilled to announce that @drugsincontext.bsky.social has received its very first Clarivate JIF (2024 JIF 2.8)!

For info, please visit our webpage (www.drugsincontext.com) or email us ([email protected])

#MedKy #PharmSky #ImpactFactor #ClarivateJCR2025
Welcome to Drugs in Context - Drugs in Context
Drugs in Context is indexed in Clarivate JCR with a 2024 JIF of 2.8 Clarivate ESCI, is a member of the Directory of Open Access Journals, and is listed on
www.drugsincontext.com
drugsincontext.bsky.social
Drugs in Context @drugsincontext.bsky.social · 3d
💊 JAK inhibitors for the treatment of palmoplantar pustulosis: a narrative review

Henriques dos Santos et al.

@drugsincontext.bsky.social #dermatology #JAKinhibitors #biologics #MedSky #PharmSky

www.drugsincontext.com/jak-inhibito...
JAK inhibitors for the treatment of palmoplantar pustulosis: a narrative review - Drugs in Context
This narrative review evaluates current evidence on the efficacy and safety of JAK inhibitors in the treatment of palmoplantar pustulosis.
www.drugsincontext.com
drugsincontext.bsky.social
Drugs in Context @drugsincontext.bsky.social · 23d
📣Management of refractory generalized myasthenia gravis with eculizumab during pregnancy and puerperium: a case report

Karaman et al.

@drugsincontext.bsky.social #immunology #neurology #myastheniagravis #pregnancy #pharmacology #MedSky #PharmSky

www.drugsincontext.com/management-o...
Management of refractory generalized myasthenia gravis with eculizumab during pregnancy and puerperium: a case report - Drugs in Context
This case report describes a successful pregnancy in a patient who received eculizumab for refractory generalized myasthenia gravis that was difficult to manage during the pre-pregnancy period.
www.drugsincontext.com
1
drugsincontext.bsky.social
Drugs in Context @drugsincontext.bsky.social · 26d
📣 In vitro antimicrobial activity of an oral spray combining 0.15% benzydamine hydrochloride and 0.5% cetylpyridinium chloride

Capezzone et al.

@drugsincontext.bsky.social #antimicrobials #respiratorytractinfections #invitro #MedSky #PharmSky

www.drugsincontext.com/in-vitro-ant...
In vitro antimicrobial activity of an oral spray combining 0.15% benzydamine hydrochloride and 0.5% cetylpyridinium chloride - Drugs in Context
This study evaluates the in vitro antimicrobial activity of a new oral spray formulation combining 0.15% benzydamine hydrochloride and 0.5% cetylpyridinium chloride. In addition modified vaccinia Anka...
www.drugsincontext.com
drugsincontext.bsky.social
Drugs in Context @drugsincontext.bsky.social · 29d
📣 Tezepelumab for early-onset severe allergic asthma with persistent airflow limitation and small airway dysfunction: a treatable traits approach

Menzella et al.

@drugsincontext.bsky.social #RespiratoryDisease #asthma #biologics #allergy
#MedSky #PharmSky

www.drugsincontext.com/tezepelumab-...
Tezepelumab for early-onset severe allergic asthma with persistent airflow limitation and small airway dysfunction: a treatable traits approach - Drugs in Context
This article describes the clinical and functional evolution of a young patient with severe early-onset allergic asthma with impaired respiratory function treated with the anti-thymic stromal lymphopo...
www.drugsincontext.com
drugsincontext.bsky.social
Drugs in Context @drugsincontext.bsky.social · Sep 22
📣 10 years of real-world data: long-term efficacy and safety of HyalOne® for hip osteoarthritis

Migliore et al.

www.drugsincontext.com/10-years-of-...

@drugsincontext.bsky.social

#Osteoarthritis #Orthopedics #HipOA #LongitudinalStudy #HyaluronicAcid #Rheumatology #MedSky #PharmSky
1 1
drugsincontext.bsky.social
Drugs in Context @drugsincontext.bsky.social · Sep 18
Nurses’ perceptions on the usability of the Hyrimoz® Sensoready® autoinjector device

Both et al.

www.drugsincontext.com/nurses-perce...

@drugsincontext.bsky.social

#nursing #gastroenterology #patientcare #usability #medicaldevices #PharmSky #MedSky
1
drugsincontext.bsky.social
Drugs in Context @drugsincontext.bsky.social · Sep 15
Treatment of vitiligo with topical ruxolitinib: a narrative review

Monteiro e Silva et al.

Review in @drugsincontext.bsky.social on topical ruxolitinib for non-segmental vitiligo.

#MedSky #dermatology #vitiligo #biologics #smallmoleculemedication #PharmSky

www.drugsincontext.com/treatment-of...
Treatment of vitiligo with topical ruxolitinib: a narrative review - Drugs in Context
This narrative study aims to review and synthesize the current evidence on the safety, efficacy and therapeutic impact of topical ruxolitinib cream in vitiligo.
www.drugsincontext.com
1
drugsincontext.bsky.social
Drugs in Context @drugsincontext.bsky.social · Sep 9
📣Real-world analysis of IL-23 inhibitors in patients with moderate-to-severe psoriasis and early musculoskeletal symptoms

Dattola et al.

#drugsincontext #dermatology #psoriasis #PsoriaticArthritis #biologics #RealWorldEvidence #MedSky #PharmSky #DermSky

www.drugsincontext.com/real-world-a...
Real-world analysis of IL-23 inhibitors in patients with moderate-to-severe psoriasis and early musculoskeletal symptoms - Drugs in Context
This article aims to evaluate the effect of IL-23 inhibitors on clinical outcomes and progression of PsA in patients with moderate-to-severe psoriasis and early musculoskeletal involvement.
www.drugsincontext.com
drugsincontext.bsky.social
Drugs in Context @drugsincontext.bsky.social · Aug 29
Celebrating milestones and embracing innovation: the next chapter for Drugs in Context

www.drugsincontext.com/celebrating-...

@drugsincontext.bsky.social #Editorial #ImpactFactor #Publishing #OpenAccess #pharmacology #drugs #treatment #MedSky #PharmSky
Celebrating milestones and embracing innovation: the next chapter for Drugs in Context - Drugs in Context
The Senior Editors of Drugs in Context are excited to announce that the journal received its first Impact Factor of 2.8 in the 2025 Edition of Journal Citation Reports by Clarivate.
www.drugsincontext.com
drugsincontext.bsky.social
Drugs in Context @drugsincontext.bsky.social · Aug 26
New publication!

Dupilumab reduces patient-reported cough and improves quality of life in patients with severe eosinophilic #asthma with or without chronic rhinosinusitis with #nasalpolyps: a real-life prospective study

Lombardi et al.

#MedSky #PharmSky
www.drugsincontext.com/dupilumab-re...
drugsincontext.bsky.social
Drugs in Context @drugsincontext.bsky.social · Aug 14
New article in @drugsincontext.bsky.social

Properties and potentialities of hyaluronic acid and eXcellent Tridimensional Reticulation as a filling agent: a review

Wong & Manni

#MedSky #PharmSky #DermSky #dermatology #skinaging #hyaluronicacid #dermalfillers

www.drugsincontext.com/properties-a...
Properties and potentialities of hyaluronic acid and eXcellent Tridimensional Reticulation as a filling agent: a review - Drugs in Context
This review summarizes the most relevant novelties in the field of HA fillers, focusing on the properties and potentialities of HA and XTR™ in the treatment of skin ageing.
www.drugsincontext.com
drugsincontext.bsky.social
Drugs in Context @drugsincontext.bsky.social · Jul 25
📢 New article in @drugsincontext.bsky.social

Use of safinamide for treatment of Parkinson disease: real-world data from Spain

Morales Casado and López Ariztegui

#MedSky #PharmSky #neurology #ParkinsonsDisease #geriatrics #pharmacology #RealWorldData

www.drugsincontext.com/use-of-safin...
Use of safinamide for treatment of Parkinson disease: real-world data from Spain - Drugs in Context
This article collects and reviews reports from Spanish authors presented at national and international conferences on the use of safinamide in patients with Parkinson disease.
www.drugsincontext.com
2
drugsincontext.bsky.social
Drugs in Context @drugsincontext.bsky.social · Jul 24
Emerging concepts in obesity management: focus on glucagon receptor agonist combinations

Sarah L. Anderson

@drugsincontext.bsky.social #MedSky #PharmSky #GLP1 #GLP1RA #obesity #obesitymanagement #pharmacology #clinicaltrials

www.drugsincontext.com/emerging-con...
Emerging concepts in obesity management: focus on glucagon receptor agonist combinations - Drugs in Context
This narrative review provides a comprehensive examination of the current landscape of GCGR-based combinations in phase III trials for the treatment of obesity.
www.drugsincontext.com
drugsincontext.bsky.social
Drugs in Context @drugsincontext.bsky.social · Jul 17
📣 New in @drugsincontext.bsky.social

Simulated client study on the dispensing practices for narcotic and psychotropic medications in community drug outlets in Ethiopia

Ketsela Zeleke et al.

#MedSky #PharmSky #pharmacy #communitypharmacy

www.drugsincontext.com/simulated-cl...
Simulated client study on the dispensing practices for narcotic and psychotropic medications in community drug outlets in Ethiopia - Drugs in Context
This study aimed to assess the extent and factors of non-prescription dispensing of narcotic and psychotropic medications at community drug retail outlets in Ethiopia.
www.drugsincontext.com
drugsincontext.bsky.social
Drugs in Context @drugsincontext.bsky.social · Jul 9
📢 New article in @drugsincontext.bsky.social

Evaluating the efficacy of #curcumin plus serratiopeptidase formulation in inflammatory #acne: a quasi-experimental study

Junaid et al.

#MedSky #PharmSky #dermatology #acne #acnevulgaris

www.drugsincontext.com/evaluating-t...
Evaluating the efficacy of curcumin plus serratiopeptidase formulation in inflammatory acne: a quasi-experimental study - Drugs in Context
This article evaluates the efficacy of a combined oral curcumin plus serratiopeptidase formulation as an adjunct to inflammatory acne therapy.
www.drugsincontext.com
drugsincontext.bsky.social
Drugs in Context @drugsincontext.bsky.social · Jun 26
📣 New article in @drugsincontext.bsky.social

Prevention of epiretinal membrane traction progression with topical indomethacin treatment: a case report and mini literature review

Lucente et al.

#MedSky #PharmSky #Ophthalmology #Pharmacology

www.drugsincontext.com/prevention-o...
Prevention of epiretinal membrane traction progression with topical indomethacin treatment: a case report and mini literature review - Drugs in Context
This article presents a case report on epiretinal membrane formation from the internal limiting membrane and examines the potential benefits of 0.5% indomethacin eye drops, supported by a brief litera...
www.drugsincontext.com
drugsincontext.bsky.social
Drugs in Context @drugsincontext.bsky.social · Jun 25
📣 New series in @drugsincontext.bsky.social

New treatment options for advanced #endometrialcarcinoma

Guest Ed: Vanda Salutari

Insights from real-world clinical experiences in Italian oncology centres

#MedSky #PharmSky #oncology #womenshealth #immunotherapy

www.drugsincontext.com/special_issu...
New treatment options for advanced endometrial carcinoma - Drugs in Context
Insights from real-world clinical experiences in Italian oncology centres.
www.drugsincontext.com
drugsincontext.bsky.social
Drugs in Context @drugsincontext.bsky.social · Jun 19
🎉 Exciting News! 🎉

We are thrilled to announce that @drugsincontext.bsky.social has received its very first Clarivate JIF (2024 JIF 2.8)!

For info, please visit our webpage (www.drugsincontext.com) or email us ([email protected])

#MedKy #PharmSky #ImpactFactor #ClarivateJCR2025
Welcome to Drugs in Context - Drugs in Context
Drugs in Context is indexed in Clarivate JCR with a 2024 JIF of 2.8 Clarivate ESCI, is a member of the Directory of Open Access Journals, and is listed on
www.drugsincontext.com
drugsincontext.bsky.social
Drugs in Context @drugsincontext.bsky.social · Jun 19
📣 New in @drugsincontext.bsky.social

Efficacy and safety of dupilumab in the treatment of moderate-to-severe atopic dermatitis: a real-life study

Morandin Lopes et al.

#MedSky #PharmSky #dermatology #atopicdermatitis #dupilumab #reallifestudy

www.drugsincontext.com/efficacy-and...
Efficacy and safety of dupilumab in the treatment of moderate-to-severe atopic dermatitis: a real-life study - Drugs in Context
The objective of this study performed in Brazil was to understand the real-life efficacy and safety of using dupilumab in patients with moderate or severe atopic dermatitis.
www.drugsincontext.com
drugsincontext.bsky.social
Drugs in Context @drugsincontext.bsky.social · Jun 17
📣 New article in @drugsincontext.bsky.social

Primary hyperhidrosis: an updated review

Maazi et al.

www.drugsincontext.com/primary-hype...

#MedSky #PharmSky #dermatology #botulinumtoxin #excessivesweat #hyperhidrosis
Primary hyperhidrosis: an updated review - Drugs in Context
This narrative review provides an updated overview of primary hyperhidrosis, with a focus on epidemiology, etiopathogenesis, clinical manifestations, diagnostic approaches and current management strat...
www.drugsincontext.com
drugsincontext.bsky.social
Drugs in Context @drugsincontext.bsky.social · Jun 9
📣 New in @drugsincontext.bsky.social

Conservative management of paediatric dacryocystitis: a collection of clinical experiences highlighting effectiveness and parental satisfaction

Russo et al.

www.drugsincontext.com/conservative...

#ophthalmology #pediatrics #dacryocystitis #MedSky #PharmSky
Conservative management of paediatric dacryocystitis: a collection of clinical experiences highlighting effectiveness and parental satisfaction - Drugs in Context
This case series suggests that a local conservative treatment, which combines Crigler massage, hypochlorous acid spray and moxifloxacin eye drops, may be an effective, well-tolerated first-line approa...
www.drugsincontext.com
drugsincontext.bsky.social
Drugs in Context @drugsincontext.bsky.social · Jun 7
New in @drugsincontext.bsky.social

Platinum-induced #ototoxicity and hearing impairment in children and adolescents

Romano et al.

#drugsincontext #oncology #chemotherapy #childhoodcancer #platinum #MedSky #PharmSky

www.drugsincontext.com/platinum-ind...
Platinum-induced ototoxicity and hearing impairment in children and adolescents - Drugs in Context
This narrative review aims to present the latest data on ototoxicity induced by platinum-based chemotherapy.
www.drugsincontext.com
1 1
drugsincontext.bsky.social
Drugs in Context @drugsincontext.bsky.social · May 22
📣 New article @drugsincontext.bsky.social

Real-world use of a hydrophilic curcumin-based oral formulation in the management of macular oedema: a collection of clinical experiences

Allegrini et al.

#ophthalmology #MacularEdema #RealWorldData #MedSky #PharmSky
www.drugsincontext.com/real-world-u...
Real-world use of a hydrophilic curcumin-based oral formulation in the management of macular oedema: a collection of clinical experiences - Drugs in Context
This is a collection of clinical experiences exploring the real-world effectiveness of a hydrophilic curcuminbased oral formulation (CHC, Diabec) in the management of macular oedema across diverse ret...
www.drugsincontext.com
drugsincontext.bsky.social
Drugs in Context @drugsincontext.bsky.social · May 12
📣 New in @drugsincontext.bsky.social

Upadacitinib for the treatment of radiographic axial spondyloarthritis — case series and review of the literature

Lopalco et al.

#drugsincontext #rheumatology #JAKinhibitors #pharmacology #MedSky #PharmSky

www.drugsincontext.com/upadacitinib...
Upadacitinib for the treatment of radiographic axial spondyloarthritis — case series and review of the literature - Drugs in Context
Four case studies described here illustrate the effectiveness of upadacitinib in a range of real-world patients with axial spondyloarthritis.
www.drugsincontext.com
drugsincontext.bsky.social
Drugs in Context @drugsincontext.bsky.social · May 7
📣 New in @drugsincontext.bsky.social

Patterns of treatment and outcomes of patients with metastatic HER2-low #breastcancer treated with CDK4/6 inhibitors and #hormonetherapy

Sottotetti et al.

#drugsincontext #oncology #medsky #realworldstudy

www.drugsincontext.com/patterns-of-...
Patterns of treatment and outcomes of patients with metastatic HER2-low breast cancer treated with CDK4/6 inhibitors and hormone therapy - Drugs in Context
This study aims to investigate, through a retrospective approach and in a real-world setting, the activity and effectiveness of CDK4/6i as first-line or second-line treatment in a HR+/HER2-low populat...
www.drugsincontext.com